SUPPRESSION OF GLUCOCORTICOID SECRETION AND ANTIPSYCHOTIC-DRUGS HAVE SIMILAR EFFECTS ON THE MESOLIMBIC DOPAMINERGIC TRANSMISSION

Citation
Pv. Piazza et al., SUPPRESSION OF GLUCOCORTICOID SECRETION AND ANTIPSYCHOTIC-DRUGS HAVE SIMILAR EFFECTS ON THE MESOLIMBIC DOPAMINERGIC TRANSMISSION, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15445-15450
Citations number
52
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
93
Issue
26
Year of publication
1996
Pages
15445 - 15450
Database
ISI
SICI code
0027-8424(1996)93:26<15445:SOGSAA>2.0.ZU;2-#
Abstract
Specific antagonists of central dopaminergic receptors constitute the major class of antipsychotic drugs (APD), Two principal effects of APD are used as criteria for the pre-clinical screening of their antipsyc hotic action: (i) inhibition of basal and depolarization-induced activ ity of mesolimbic dopaminergic neurons; (ii) antagonism of the locomot or effects of dopaminergic agonists, Given that glucocorticoid hormone s in animals increase dopamine release and dopamine-mediated behaviors and that high levels of glucocorticoids can induce psychotic symptoms In humans, these experiments examined whether inhibition of endogenou s glucocorticoids might have AD-like effects on mesolimbic dopaminergi c transmission in rats, It is shown that suppression of glucocorticoid secretion by adrenalectomy profoundly decreased (by greater than 50%) : (i) basal dopaminergic release and the release of dopamine induced b y a depolarizing stimulus such as morphine (2 mg/kg, s.c.), as measure d in the nucleus accumbens of freely moving animals by microdialysis; (ii) the locomotor activity induced by the direct dopaminergic agonist apomorphine, The effects of adrenalectomy were glucocorticoid specifi c given that they were reversed by the administration of glucocorticoi ds at doses within the physiological range, Despite its profound dimin ution of dopaminergic neurotransmission, adrenalectomy neither modifie d the number of mesencephalic dopaminergic neurons nor induced gliosis in the mesencephalon or In the nucleus accumbens, as shown by tyrosin e hydroxylase and glial fibrillary acidic protein immunostaining. In c onclusion, these findings suggest that blockade of central effects of glucocorticoids might open new therapeutic strategies of behavioral di sturbances.